Send me a link:

*Text messaging rates may apply.

 Dow Down0.72% Nasdaq Down0.50%

Taro Pharmaceutical Industries Ltd. (TARO)

-NYSE
143.44 Down 1.27(0.88%) Jul 25, 4:02PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 1998
Total Revenue 13,499  
Cost of Revenue6,046  
Gross Profit 7,453  
Operating Expenses
Research Development2,275  
Selling General and Administrative4,604  
Non Recurring -  
Others -  
Total Operating Expenses -  
Operating Income or Loss 574  
Income from Continuing Operations
Total Other Income/Expenses Net(565)
Earnings Before Interest And Taxes9  
Interest Expense -  
Income Before Tax9  
Income Tax Expense(66)
Minority Interest14  
Net Income From Continuing Ops89  
Non-recurring Events
Discontinued Operations -  
Extraordinary Items -  
Effect Of Accounting Changes -  
Other Items -  
Net Income 89  
Preferred Stock And Other Adjustments -  
Net Income Applicable To Common Shares 89  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.